Loading company…
Qurient Therapeutics is a Seongnam, South Korea biopharmaceutical company developing treatments for oncology and inflammatory diseases.
Qurient is a clinical-stage company developing novel therapeutics for oncology and inflammatory diseases. Established in 2008 and based in Seongnam, South Korea, the company saw DongKoo Bio&Pharma acquire 1.34 million shares at KRW 5,952 apiece, for KRW 8 billion, in a PIPE transaction in April 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in